Global - February 24 2021
What happens when a generic or biosimilar enters a market where patents are in force? What preliminary measures exist? On February 23, our…
Céline Bey, Daniela Shaw, Erin Creber, Paul Inman.
Global - February 1 2021
What does it take for a second medical use to be sufficiently disclosed? A list of indications in the application? Clinical data? Or something…
Vladislav Ugryumov, Alex Gloor, Jian Xu, Paul Inman.
United Kingdom - January 22 2021
As the scientific community continues to tackle some of the world's most challenging diseases, research and innovation has led to the discovery of new…
Vladislav Ugryumov, Alex Gloor, Jian Xu, Paul Inman.
Canada - December 31 2020
The coming-into-force date of the Regulations Amending the Patented Medicines Regulations ("the Amendments") has been delayed by 6 months until July 1…
Alex Gloor, Jenny Thistle.
Global - June 23 2020
To ensure your patent catches potential infringements in the future, you must plan carefully and pay close attention to patent drafting. How is the…
Jian Xu, Paul Inman, Ruben Dzhermakyan, Sonia M. Ziesche.